Cite
HARVARD Citation
Coyle, C. et al. (2017). Randomised clinical trial: addition of alginate‐antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Alimentary pharmacology & therapeutics. 45 (12), pp. 1524-1533. [Online].